Bioray Biotech Co., Ltd (TPEX:7561)
Taiwan · Delayed Price · Currency is TWD 23.35
+0.25 (1.08%)
Nov 6, 2025, 10:19 AM CST
Bioray Biotech Market Cap
Bioray Biotech has a market cap or net worth of 690.82 million as of November 6, 2025. Its market cap has increased by 0.24% in one year.
Market Cap
690.82M
Enterprise Value
587.26M
Revenue
230.06M
Ranking
n/a
PE Ratio
22.69
Stock Price
23.35
Market Cap Chart
Since July 6, 2020, Bioray Biotech's market cap has decreased from 1.94B to 690.82M, a decrease of -64.40%. That is a compound annual growth rate of -17.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 690.82M | 8.71% |
| Dec 31, 2024 | 635.45M | -31.65% |
| Dec 29, 2023 | 929.63M | 3.17% |
| Dec 30, 2022 | 901.05M | -30.18% |
| Dec 30, 2021 | 1.29B | 56.23% |
| Dec 31, 2020 | 826.00M | -57.44% |
| Jul 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 226.45B |
| PharmaEssentia | 169.97B |
| Bora Pharmaceuticals Co., LTD. | 79.56B |
| Lotus Pharmaceutical | 74.95B |
| Lumosa Therapeutics | 34.70B |
| Oneness Biotech | 29.17B |
| Pegavision | 26.33B |
| Center Laboratories | 26.28B |